Nontuberculous Mycobacterium Infection Clinical Trial
Official title:
Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.
The MAC-HS study is an open label, randomized control trial of hypertonic saline in pulmonary M. avium complex patients. Eligible patients who consent to participate will be randomized 1:1 to hypertonic saline or standard of care for 12 weeks. All patients in the treatment group will take inhaled hypertonic saline twice daily for 12 weeks. Patients may continue with other airway clearance methods (i.e. flutter, acapella valve, aerobika, postural drainage, huff cough, percussion). Patients may also be treated with antibiotics targeted at other pathogens if an exacerbation occurs. Patients may also be actively treated with inhaled corticosteroid at the time of enrollment, with dosing adjustments during the trial discouraged. Patients with disease progression at any time can be discontinued from the study treatment and treated according to ATS/IDSA guidelines at the discretion of the primary investigator. However, such patients will still complete the 12 week final visit, sputum collection and AE assessment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03532438 -
WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments
|
||
| Recruiting |
NCT04294043 -
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
|
Phase 1 | |
| Recruiting |
NCT05280886 -
Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
|
||
| Completed |
NCT04024423 -
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
|
||
| Completed |
NCT03748992 -
A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
|
Phase 2 | |
| Active, not recruiting |
NCT06004037 -
Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex
|
Phase 2 | |
| Enrolling by invitation |
NCT06262282 -
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
|
||
| Recruiting |
NCT03672630 -
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03120481 -
Controls for Respiratory Diseases
|
N/A |